Registration number:
for the Period from 23 January 2024 to
Bionet Investments Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
Bionet Investments Limited
Company Information
|
Directors |
Mr D B Pearl Mr M W Barton |
|
Company secretary |
Mr D B Pearl |
|
Registered office |
|
Bionet Investments Limited
(Registration number: 15434371)
Balance Sheet as at 31 January 2025
|
Note |
2025 |
|
|
Current assets |
||
|
Stocks |
|
|
|
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
|
|
Total assets less current liabilities |
( |
|
|
Provisions for liabilities |
( |
|
|
Net liabilities |
( |
|
|
Capital and reserves |
||
|
Called up share capital |
10 |
|
|
Retained earnings |
(1,388) |
|
|
Shareholders' deficit |
(1,378) |
For the financial period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.
Approved and authorised by the
|
......................................... |
Bionet Investments Limited
Notes to the Unaudited Financial Statements for the Period from 23 January 2024 to 31 January 2025
|
General information |
The company is a private company limited by share capital, incorporated in United Kingdom.
The address of its registered office is:
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Going concern
The directors have reviewed the company's projected profits and cash flow and consider that the company will be able to settle its liabilities as and when they fall due for the foreseeable future. This assessment has been made taking into account a period of at least 12 months from the approval and signing of these financial statements. The company is in the pre-revenue stage and a significant order book has since been established. Accordingly, the financial statements have been prepared on a going concern basis and do not include any adjustments that would result if the company was unable to continue as a going concern.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.
Bionet Investments Limited
Notes to the Unaudited Financial Statements for the Period from 23 January 2024 to 31 January 2025
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Financial instruments
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss. Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Bionet Investments Limited
Notes to the Unaudited Financial Statements for the Period from 23 January 2024 to 31 January 2025
|
Staff numbers |
The average number of persons employed by the company (including directors) during the period, was
|
Stocks |
|
2025 |
|
|
Work in progress |
|
|
Debtors |
|
2025 |
|
|
Other debtors |
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
|
Note |
2025 |
|
|
Due within one year |
||
|
Loans and borrowings |
|
|
Loans and borrowings |
Current loans and borrowings
|
2025 |
|
|
Amounts owed to related parties |
|
|
Director's loan account |
|
|
|
|
The director's loan account is non-interest bearing and repayable on demand.
Amounts owed to related parties is an interest free, repayable on demand loan from Rotherham Taylor Ltd, of which Mr M W Barton is a director.